Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCara Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.65 | -$0.25 | -$0.40 |
| Q2 2024 | 1 | -$0.45 | -$0.17 | -$0.27 |
| Q3 2024 | 1 | -$0.39 | -$0.15 | -$0.24 |
| Q4 2024 | 2 | -$0.27 | -$0.11 | -$0.20 |
| Q1 2025 | 1 | -$0.33 | -$0.13 | -$0.20 |
| Q2 2025 | 1 | -$0.34 | -$0.13 | -$0.21 |
| Q3 2025 | 1 | -$0.38 | -$0.14 | -$0.23 |
| Q4 2025 | 1 | -$0.33 | -$0.13 | -$0.20 |
Cara Therapeutics, Inc. Earnings Date And Information
Cara Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.25 by $0.1. The company had revenue of 2.56 M for the quarter and had revenue of 20.97 M for the year. Cara Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.19 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. Cara Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Cara Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.25 | -$0.23 | 0.02 | $2.02 M | $2.56 M |
| 08/14/2024 | Q2 2024 | -$0.29 | -$0.37 | -0.08 | $1.18 M | $991,000 |
| 05/13/2024 | Q1 2024 | -$0.38 | -$0.56 | -0.18 | $2.14 M | |
| 03/06/2024 | Q4 2023 | -$0.59 | $3.00 M | |||
| 11/13/2023 | Q3 2023 | -$0.53 | -$0.52 | 0.01 | $9.95 M | $4.87 M |
| 08/07/2023 | Q2 2023 | -$0.56 | -$0.58 | -0.02 | $6.50 M | $6.93 M |
| 05/15/2023 | Q1 2023 | -$0.53 | -$0.48 | 0.05 | $6.17 M | |
| 03/06/2023 | Q4 2022 | -$0.33 | -$0.55 | -0.22 | $3.26 M | |
| 11/07/2022 | Q3 2022 | -$0.42 | -$0.42 | 0 | $8.84 M | $10.81 M |
| 08/08/2022 | Q2 2022 | -$0.28 | -$0.07 | 0.21 | $21.11 M | $23.00 M |
| 05/09/2022 | Q1 2022 | -$0.56 | -$0.52 | 0.04 | $4.79 M | |
| 03/01/2022 | Q4 2021 | -$0.50 | -$0.63 | -0.13 | $821,000 | |
| 11/08/2021 | Q3 2021 | -$0.36 | -$0.02 | 0.34 | $15.59 M | $20.27 M |
| 08/09/2021 | Q2 2021 | -$0.55 | -$0.61 | -0.06 | $2.59 M | $0 |
| 05/10/2021 | Q1 2021 | -$0.62 | -$0.47 | 0.15 | $1.94 M | |
| 02/25/2021 | Q4 2020 | $0.36 | $1.68 | 1.32 | $112.09 M | |
| 11/09/2020 | Q3 2020 | -$0.68 | -$0.35 | 0.33 | $4.73 M | $9.27 M |
| 08/10/2020 | Q2 2020 | -$0.68 | -$0.54 | 0.14 | $5.01 M | $5.63 M |
| 05/11/2020 | Q1 2020 | -$0.63 | -$0.62 | 0.01 | $8.09 M | |
| 02/27/2020 | Q4 2019 | -$0.62 | -$0.61 | 0.01 | $4.51 M |
Cara Therapeutics, Inc. Earnings: FAQ's
When is Cara Therapeutics, Inc.'s earnings date?
Cara Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
Did Cara Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Cara Therapeutics, Inc. (:CARA) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.25 by $0.1.
How can I listen to Cara Therapeutics, Inc.'s earnings conference
call?
The conference call for Cara Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Cara Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Cara Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Cara Therapeutics, Inc. generate each year?
Cara Therapeutics, Inc. (:CARA) has a recorded annual revenue of $20.97 M.
How much profit does Cara Therapeutics, Inc. generate each year?
Cara Therapeutics, Inc. (:CARA) has a recorded net income of $20.97 M. Cara Therapeutics, Inc. has generated $-2.19 earnings per share over the last four quarters.
What is Cara Therapeutics, Inc.'s price-to-earnings ratio?
Cara Therapeutics, Inc. (:CARA) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.02.